Literature DB >> 18239807

Role of genetically determined production of immunoregulatory cytokines in immunopathogenesis of chronic viral hepatitides.

I O Naslednikova1, V I Konenkov, N V Ryazantseva, V V Novitskii, S B Tkachenko, A P Zima, V V Avdoshina, E I Beloborodova, E V Beloborodova, V V Dortman.   

Abstract

Immunopathogenesis of chronic viral hepatitides was studied by modern immunological, molecular, genetic methods. We revealed an imbalance in the production of immunoregulatory cytokines by mononuclear leukocytes (primarily of the Th2 type). The risk of progression and chronic course of viral hepatitides in Caucasian population was associated with alleles of promoter regions -330G and -592A in the IL-2 and IL-10 genes, respectively, as well as with the T/T genotype of the polymorphic region C590T in the IL-4 gene. The C/C genotype of the IL-10 gene promoter region C592A was shown to be a factor determining resistance to long-term persistence of hepatitis B and C viruses.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18239807     DOI: 10.1007/s10517-007-0220-x

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN: 0007-4888            Impact factor:   0.804


  3 in total

1.  Relationship between circulating interleukin-10 and histological features in patients with chronic C hepatitis.

Authors:  Cosimo Marcello Bruno; Maria Valenti; Gaetano Bertino; Annalisa Ardiri; Alfredo Amoroso; Maria Consolo; Clorinda Maria Mazzarino; Sergio Neri
Journal:  Ann Saudi Med       Date:  2011 Jul-Aug       Impact factor: 1.526

2.  Role of IL-4 gene polymorphisms in HBV-related hepatocellular carcinoma in a Chinese population.

Authors:  Yu Lu; Zhitong Wu; Qiliu Peng; Liping Ma; Xiaolian Zhang; Jiangyang Zhao; Xue Qin; Shan Li
Journal:  PLoS One       Date:  2014-10-08       Impact factor: 3.240

Review 3.  Association Between IL-4 Polymorphisms and Risk of Liver Disease: An Updated Meta-Analysis.

Authors:  Zhitong Wu; Wenzhou Qin; Jie Zeng; Chunni Huang; Yu Lu; Shan Li
Journal:  Medicine (Baltimore)       Date:  2015-09       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.